Orchid Pharma Limited has submitted a regulatory intimation to the National Stock Exchange of India Limited and BSE Limited regarding a scheduled investor roadshow. The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Mr. Mridul Dhanuka, Whole Time Director of the company, will be participating in the event. The roadshow is scheduled as a physical group meeting in Mumbai over three days: Monday, September 28, 2026; Tuesday, September 29, 2026; and Wednesday, September 30, 2026.
The company has noted that this schedule is subject to change due to unforeseen exigencies on the part of either the investors or the company, and any such changes will be communicated.
A critical disclaimer states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared by the company during this investor meet.